Description

SLU-PP-332 is a research-grade synthetic peptide derivative designed to act as a potent agonist of the REV-ERB family of nuclear receptors, specifically REV-ERBα and REV-ERBβ. These receptors are critical regulators of circadian rhythm, lipid and glucose metabolism, mitochondrial function, and inflammatory response. SLU-PP-332 enhances REV-ERB signaling by promoting the transcriptional repression of target genes, making it an important tool in metabolic and chronobiology research.

Warning: For Research Purposes Only. Injectables are delivered in a freeze-dried (powder) state, contained within a sterile vial. Use requires: Bacteriostatic Water for reconstitution.